GlassScriptPhysician profile
Colin Gold
NPI 1457874745
$1,808.86
in general payments reported to CMS, 2019-2025
9 companies · $718 in 2025
The $718 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.07 · 2022: $141 · 2023: $465 · 2024: $398 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,223 · Travel and Lodging: $316 · Entertainment: $42.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,223.01 |
| Travel and Lodging | $316.00 |
| Entertainment | $42.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $684.78 | 2021-2025 | Unid_pass, Mazor X System, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Globus Medical, INC. | $532.15 | 2024-2025 | Excelsius Gps, Omnia, Sable |
| Centinel Spine, LLC | $316.00 | 2023 | Prodisc L |
| Carbofix Spine INC | $88.90 | 2025 | |
| Omniscient Neurotechnology America LTD | $64.00 | 2022 | |
| Spinal Elements, INC. | $42.06 | 2023 | |
| Bioventus LLC | $33.37 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Stryker Corporation | $25.14 | 2025 | Everest Spinal System |
| Depuy Synthes Sales INC. | $22.46 | 2025 | Trialtis, Symphony, Teligen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Gold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.